Edition:
United Kingdom

People: CellaVision AB (CEVI.ST)

CEVI.ST on Stockholm Stock Exchange

366.50SEK
23 Jul 2019
Change (% chg)

14.50kr (+4.12%)
Prev Close
352.00kr
Open
350.00kr
Day's High
369.00kr
Day's Low
348.00kr
Volume
39,650
Avg. Vol
39,124
52-wk High
369.00kr
52-wk Low
185.00kr

Malm Bernsten, Anna 

Ms. Anna Malm Bernsten has served as Independent Member of the Board of Directors of CellaVision AB since April 29, 2010. She is Chief Executive Officer of Bernsten Konsult AB. She is Chairman of the Board of Medivir AB and Bjorn Axen Institute AB, as well as Member of the Board of Pagengruppen AB. She was Chairman of the Board of Oatly AB during 2016. Her former positions include Chief Executive Officer and President of Carmeda AB and management positions at Pharmacia & Upjohn and GE Healthcare Life Sciences. She holds a Master of Science degree in Chemical Engineering.

Basic Compensation

Total Annual Compensation, SEK 200,000
Restricted Stock Award, SEK --
Long-Term Incentive Plans, SEK --
All Other, SEK --
Fiscal Year Total, SEK 200,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --